MedPath

Pfizer Ireland Pharmaceuticals

🇸🇪Sweden
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

25

NMPA:10
PHILIPPINES:8
SFDA:4
+2 more agencies

Drug Approvals

Ceftazidime and Avibactam Sodium for Injection

Product Name
思福妥
Approval Number
国药准字HJ20190038
Approval Date
Apr 3, 2024
NMPA

Venlafaxine Hydrochloride Sustained-Release Capsules

Product Name
怡诺思
Approval Number
J20160079
Approval Date
May 26, 2020
NMPA

Venlafaxine Hydrochloride Sustained-Release Capsules

Product Name
怡诺思
Approval Number
国药准字J20160079
Approval Date
May 26, 2020
NMPA

Venlafaxine Hydrochloride Sustained-Release Capsules

Product Name
怡诺思
Approval Number
J20160078
Approval Date
May 26, 2020
NMPA

Venlafaxine Hydrochloride Sustained-Release Capsules

Product Name
怡诺思
Approval Number
国药准字J20160078
Approval Date
May 26, 2020
NMPA

Ceftazidime and Avibactam Sodium for Injection

Product Name
思福妥
Approval Number
H20190038
Approval Date
May 21, 2019
NMPA

Etanercept Solution for Injection

Product Name
恩利
Approval Number
S20180011
Approval Date
May 17, 2018
NMPA

Atorvastatin Calcium

Product Name
阿托伐他汀钙
Approval Number
H20171135
Approval Date
Sep 13, 2017
NMPA

Piroxicam

Product Name
吡罗昔康
Approval Number
H20160270
Approval Date
May 10, 2016
NMPA

Piroxicam

Product Name
吡罗昔康
Approval Number
H20160271
Approval Date
May 10, 2016
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.